Does USTEKINUMAB Cause Clostridium difficile infection? 440 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 440 reports of Clostridium difficile infection have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.5% of all adverse event reports for USTEKINUMAB.
440
Reports of Clostridium difficile infection with USTEKINUMAB
0.5%
of all USTEKINUMAB reports
3
Deaths
174
Hospitalizations
How Dangerous Is Clostridium difficile infection From USTEKINUMAB?
Of the 440 reports, 3 (0.7%) resulted in death, 174 (39.5%) required hospitalization, and 3 (0.7%) were considered life-threatening.
Is Clostridium difficile infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 440 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Clostridium difficile infection?
ADALIMUMAB (1,502)
INFLIXIMAB (1,419)
VEDOLIZUMAB (1,130)
LENALIDOMIDE (814)
VANCOMYCIN (743)
METRONIDAZOLE (619)
PREDNISONE (618)
METHOTREXATE (588)
RITUXIMAB (532)
CIPROFLOXACIN (508)
Which USTEKINUMAB Alternatives Have Lower Clostridium difficile infection Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE